• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国成年系统性硬化症患者肺动脉高压的患病率:一项超声心动图初步筛查研究的结果

Prevalence of Pulmonary Arterial Hypertension in Korean Adult Patients with Systemic Sclerosis: Result of a Pilot Echocardiographic Screening Study.

作者信息

Yoo Su-Jin, Park Jae-Hyeong, Park Yunseon, Lee Jae-Hwan, Sun Byung-Joo, Kim Jinhyun, Yoo In Seol, Shim Seung Cheol, Kang Seong Wook

机构信息

Division of Rheumatology, Department of Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea.

Division of Cardiology, Department of Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Korea.

出版信息

J Cardiovasc Ultrasound. 2016 Dec;24(4):312-316. doi: 10.4250/jcu.2016.24.4.312. Epub 2016 Dec 28.

DOI:10.4250/jcu.2016.24.4.312
PMID:28090259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5234342/
Abstract

BACKGROUND

Pulmonary arterial hypertension (PAH) is a major cause of morbidity and mortality among patients with systemic sclerosis (SSc). Early detection and prompt treatment of PAH associated with SSc (SSc-PAH) result in better prognosis. We conducted echocardiographic study to presume the prevalence of PAH in Korean adult SSc patients and to diagnose SSc-PAH in their early stages with right heart catheterization (RHC).

METHODS

We performed free of charge echocardiographic study including 37 adult SSc patients at the Chungnam National University Hospital. The possibility of PAH is determined by the estimation of pulmonary arterial pressure by peak tricuspid regurgitation velocity of > 3.0 m/s. Patients with possible PAH were recommended to undergo RHC to confirm the diagnosis.

RESULTS

In 37 patients, 8 patients were suspected with PAH. Among them, 6 patients agreed to be examined with RHC, and 4 were confirmed with PAH. The prevalence of possible PAH was 21.6% (8 of 37 patients), and that of confirmed PAH was 10.8% (4 of 37 patients). Four patients who were confirmed with SSc-PAH through RHC have been treated with specific pulmonary vasodilators and maintained stable.

CONCLUSION

Eight patients (21.6%) were possible PAH and 4 (10.8%) were diagnosed as SSc-PAH by RHC after the echocardiographic screening study of 37 adult SSc patients.

摘要

背景

肺动脉高压(PAH)是系统性硬化症(SSc)患者发病和死亡的主要原因。早期发现并及时治疗与SSc相关的PAH(SSc-PAH)可带来更好的预后。我们进行了超声心动图研究,以推测韩国成年SSc患者中PAH的患病率,并通过右心导管检查(RHC)在早期诊断SSc-PAH。

方法

我们在忠南国立大学医院对37例成年SSc患者免费进行了超声心动图研究。通过三尖瓣反流峰值速度估计肺动脉压> 3.0 m/s来确定PAH的可能性。建议可能患有PAH的患者接受RHC以确诊。

结果

37例患者中,8例疑似PAH。其中,6例患者同意接受RHC检查,4例确诊为PAH。可能PAH的患病率为21.6%(37例患者中的8例),确诊PAH的患病率为10.8%(37例患者中的4例)。通过RHC确诊为SSc-PAH的4例患者已接受特异性肺血管扩张剂治疗并保持稳定。

结论

在对37例成年SSc患者进行超声心动图筛查研究后,8例(21.6%)可能患有PAH,4例(10.8%)通过RHC被诊断为SSc-PAH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5234342/d23719848c95/jcu-24-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5234342/d23719848c95/jcu-24-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b034/5234342/d23719848c95/jcu-24-312-g001.jpg

相似文献

1
Prevalence of Pulmonary Arterial Hypertension in Korean Adult Patients with Systemic Sclerosis: Result of a Pilot Echocardiographic Screening Study.韩国成年系统性硬化症患者肺动脉高压的患病率:一项超声心动图初步筛查研究的结果
J Cardiovasc Ultrasound. 2016 Dec;24(4):312-316. doi: 10.4250/jcu.2016.24.4.312. Epub 2016 Dec 28.
2
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.系统性硬化症中肺动脉高压的早期检测:一项法国全国性前瞻性多中心研究。
Arthritis Rheum. 2005 Dec;52(12):3792-800. doi: 10.1002/art.21433.
3
Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.使用临床和超声心动图标准评估系统性硬化症患者的肺动脉高压
Am J Med Sci. 2016 Oct;352(4):343-347. doi: 10.1016/j.amjms.2016.07.007. Epub 2016 Jul 16.
4
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.基于证据的系统性硬化症肺动脉高压检测:DETECT 研究。
Ann Rheum Dis. 2014 Jul;73(7):1340-9. doi: 10.1136/annrheumdis-2013-203301. Epub 2013 May 18.
5
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.在法国一项全国性多中心纵向研究中,系统性硬化症相关肺动脉高压的三年发病率。
Arthritis Rheum. 2009 Jun;60(6):1831-9. doi: 10.1002/art.24525.
6
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.系统性硬化症相关肺动脉高压与特发性肺动脉高压治疗中右心室功能变化的差异。
Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.
7
Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension.低剂量多巴酚丁胺负荷超声心动图用于在静息超声心动图对肺动脉高压诊断不明确的特定系统性硬化症患者中早期检测肺动脉高压。
J Clin Med. 2021 Sep 2;10(17):3972. doi: 10.3390/jcm10173972.
8
In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.在系统性硬化症中,TAPSE/sPAP 比值可与 DETECT 算法联合用于肺动脉高压的诊断。
Rheumatology (Oxford). 2022 May 30;61(6):2450-2456. doi: 10.1093/rheumatology/keab748.
9
Predictive Value of the DETECT Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: Findings from an Italian Observational Study.DETECT算法对系统性硬化症患者肺动脉高压的预测价值:一项意大利观察性研究的结果
J Clin Med. 2025 Jan 20;14(2):638. doi: 10.3390/jcm14020638.
10
Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.捷克共和国的系统性硬化症相关肺动脉高压。
Clin Rheumatol. 2012 Mar;31(3):557-61. doi: 10.1007/s10067-011-1896-x. Epub 2011 Nov 22.

引用本文的文献

1
Epidemiology and Treatment of Systemic Sclerosis in Korea.韩国系统性硬化症的流行病学与治疗
J Rheum Dis. 2022 Oct 1;29(4):200-214. doi: 10.4078/jrd.22.0029.
2
Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker.成纤维细胞生长因子23与α-klotho指数与系统性硬化症活动相关:一种新型疾病活动标志物的提议。
J Clin Med. 2018 Dec 17;7(12):558. doi: 10.3390/jcm7120558.
3
Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

本文引用的文献

1
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.韩国肺动脉高压注册研究的基线特征
J Korean Med Sci. 2015 Oct;30(10):1429-38. doi: 10.3346/jkms.2015.30.10.1429. Epub 2015 Sep 12.
2
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会(ESC)/欧洲呼吸学会(ERS)肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗联合工作组:得到以下组织认可:欧洲儿科和先天性心脏病协会(AEPC)、国际心肺移植学会(ISHLT)。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
3
结缔组织病相关肺动脉高压的筛查和诊断方法的更新。
Semin Arthritis Rheum. 2019 Jun;48(6):1059-1067. doi: 10.1016/j.semarthrit.2018.10.010. Epub 2018 Oct 14.
4
Issues on Estimated Pulmonary Artery Pressure in Liver Transplant Candidates.肝移植候选者肺动脉压估计的相关问题
J Cardiovasc Imaging. 2018 Jun;26(2):61-62. doi: 10.4250/jcvi.2018.26.e7. Epub 2018 Jun 21.
5
Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis.短期服用辛伐他汀对血脂正常的系统性硬化症患者的内皮激活标志物无影响。
J Int Med Res. 2018 May;46(5):1893-1901. doi: 10.1177/0300060518762681. Epub 2018 Mar 20.
6
The Importance of Echocardiographic Screening for Pulmonary Arterial Hypertension in Korean Patients with Systemic Sclerosis.超声心动图筛查对韩国系统性硬化症患者肺动脉高压的重要性
J Cardiovasc Ultrasound. 2016 Dec;24(4):276-277. doi: 10.4250/jcu.2016.24.4.276. Epub 2016 Dec 28.
Definitions and diagnosis of pulmonary hypertension.肺动脉高压的定义和诊断。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032.
4
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.2013 年系统性硬化症分类标准:美国风湿病学会/欧洲抗风湿病联盟合作倡议。
Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424.
5
Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.用于系统性硬化症中肺动脉高压诊断的影像学方式。
Nat Rev Rheumatol. 2012 Feb 7;8(4):203-13. doi: 10.1038/nrrheum.2012.2.
6
Assessment of right ventricular structure and function in pulmonary hypertension.肺动脉高压时右心室结构和功能的评估
J Cardiovasc Ultrasound. 2011 Sep;19(3):115-25. doi: 10.4250/jcu.2011.19.3.115. Epub 2011 Sep 30.
7
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.系统性硬化症患者肺动脉高压的筛查:诊断时的临床特征及长期生存率
Arthritis Rheum. 2011 Nov;63(11):3522-30. doi: 10.1002/art.30541.
8
Pulmonary arterial hypertension associated with systemic sclerosis.系统性硬皮病相关肺动脉高压。
Expert Rev Respir Med. 2011 Apr;5(2):267-79. doi: 10.1586/ers.11.18.
9
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.系统性硬化症死亡的原因和危险因素:来自 EULAR 硬皮病试验和研究 (EUSTAR) 数据库的研究。
Ann Rheum Dis. 2010 Oct;69(10):1809-15. doi: 10.1136/ard.2009.114264. Epub 2010 Jun 15.
10
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.从 REVEAL 研究中对结缔组织病相关肺动脉高压的特征分析:确定系统性硬化症为一种独特表型。
Chest. 2010 Dec;138(6):1383-94. doi: 10.1378/chest.10-0260. Epub 2010 May 27.